Drug Type Small molecule drug |
Synonyms Vapedrine, CH 123, CH-123 + [2] |
Target |
Action inhibitors |
Mechanism HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H18N2O5 |
InChIKeyIRGLQUMAHASUTG-MDWBIBFBSA-N |
CAS Registry101197-99-3 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hyperlipidemias | Phase 3 | Hungary | - | |
| Hyperlipidemias | Phase 3 | - | - |





